Addressing Weight Issues in Menopausal Women

Addressing Weight Issues in Menopausal Women

On-Demand Webcast

Jeffrey P. Levine, MD, MPH
Professor and Director, Women's Health Programs
Departments of Family Medicine and Community Health
UMDNJ-Robert Wood Johnson Medical School
New Brunswick, New Jersey
Medical Director
Interactive Health Solutions
Hillsborough, New Jersey

Intended Learners

This enduring activity is designed for primary care physicians, nurse practitioners, nurses, physician assistants, registered dietitians, certified diabetes educators, pharmacists and other related healthcare professionals involved in the treatment of patients with cardiometabolic conditions.

Learning Objectives

After completing this activity, participants should be able to:

  • Describe the relationship between hormonal changes during perimenopause and increases in total body fat and abdominal body fat
  • Analyze non-hormonal factors that significantly contribute to weight gain in peri- and postmenopausal women
  • Define the increased risk of cardiovascular and metabolic disease associated with these changes
  • Discuss the potential benefits of hormonal therapy for improving insulin sensitivity and reducing type 2 diabetes in high risk women
  • Advocate increased physical activity in all perimenopausal women to minimize weight gain and body fat changes during the menopausal transition
Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10 online post-test questions with a score of 70% or better, and complete the evaluation form.

After successful completion of the post-test and evaluation form online at, participants may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: October 10, 2014
Expiration Date: October 10, 2017
Estimated time to complete: 1 hour

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

The evaluation is accessible after the activity via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to


North American Center for Continuing Medical Education (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


NACCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.


This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

This continuing nursing education activity awards up to 0.25 pharmacology credit.

CPE for Pharmacists

This activity is approved for 1.0 contact hours (.10 CEUs) of continuing pharmacy education (UAN 0276-0000-14-056-H01-P).

This educational activity is a knowledge-based activity.

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Senior Manager, Accreditation & Compliance, NACCME, in writing at 104 Windsor Center Drive, Suite 200, East Windsor, NJ 08520. The Senior Manager, Accreditation & Compliance will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation and Compliance, NACCME, may be made for a second level of review.

CPE for Dietitians

North American Center for Continuing Medical Education, LLC (NACCME) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education units (CPEUs) for completion of this activity/material. Level 3 Synthesis, CDR Accredited Provider # HMOO1.

Independent Clinical Reviewer: Robert M. Huster, MD, Director, American Board of Obesity Medicine, Liberty, Missouri

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Planning Committee

The planning committee comprises of Robert M. Huster, MD; Jeffrey P. Levine, MD, MPH; Susie Seaman, NP; and Steven Chavez, Mary Johnson, Randy Robbin, John Savage, and Margaret Stefan, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Levine: Advisory Board—Bayer, Pfizer, Shionogi; Speakers' Bureau—Merck

Ms. Seaman: Consultant—Molnlycke Health Care, Coloplast Corporation, Z-Medica; Scientific Advisor – Smith & Nephew Speakers Bureau

Dr. Huster disclosed no relevant financial relationships with any commercial interests.

Mr. Chavez, Ms. Johnson, Mr. Robbin, Mr. Savage, and Ms. Stefan disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed no off label/unapproved uses of drugs and/or devices will be discussed in the presentations.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2015 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.